skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:066703/0974   Pages: 9
Recorded: 03/08/2024
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 11
1
Patent #:
10030005
Issue Dt:
07/24/2018
Application #:
15340428
Filing Dt:
11/01/2016
Publication #:
US20170121312
Pub Dt:
05/04/2017
Title:
INHIBITORS OF RET
2
Patent #:
10584114
Issue Dt:
03/10/2020
Application #:
16041719
Filing Dt:
07/20/2018
Publication #:
US20190185454
Pub Dt:
06/20/2019
Title:
INHIBITORS OF RET
3
Patent #:
11279688
Issue Dt:
03/22/2022
Application #:
16775646
Filing Dt:
01/29/2020
Publication #:
US20200407341
Pub Dt:
12/31/2020
Title:
INHIBITORS OF RET
4
Patent #:
11963958
Issue Dt:
04/23/2024
Application #:
17061743
Filing Dt:
10/02/2020
Publication #:
US20210085680
Pub Dt:
03/25/2021
Title:
RET INHIBITOR FOR USE IN TREATING CANCER HAVING A RET ALTERATION
5
Patent #:
11273160
Issue Dt:
03/15/2022
Application #:
17127041
Filing Dt:
12/18/2020
Publication #:
US20210100799
Pub Dt:
04/08/2021
Title:
RET INHIBITOR FOR USE IN TREATING CANCER HAVING A RET ALTERATION
6
Patent #:
NONE
Issue Dt:
Application #:
17267149
Filing Dt:
02/09/2021
Publication #:
US20210308134
Pub Dt:
10/07/2021
Title:
TREATMENT OF EGFR-MUTANT CANCER
7
Patent #:
11872192
Issue Dt:
01/16/2024
Application #:
17377885
Filing Dt:
07/16/2021
Publication #:
US20220175773
Pub Dt:
06/09/2022
Title:
RET INHIBITOR FOR USE IN TREATING CANCER HAVING A RET ALTERATION
8
Patent #:
NONE
Issue Dt:
Application #:
17669785
Filing Dt:
02/11/2022
Publication #:
US20220315560
Pub Dt:
10/06/2022
Title:
INHIBITORS OF RET
9
Patent #:
NONE
Issue Dt:
Application #:
18000166
Filing Dt:
11/29/2022
Publication #:
US20230203009
Pub Dt:
06/29/2023
Title:
PRALSETINIB PHARMACEUTICAL COMPOSITIONS
10
Patent #:
NONE
Issue Dt:
Application #:
18000168
Filing Dt:
11/29/2022
Publication #:
US20230295121
Pub Dt:
09/21/2023
Title:
SOLID FORMS OF PRALSETINIB
11
Patent #:
NONE
Issue Dt:
Application #:
18255402
Filing Dt:
06/01/2023
Publication #:
US20240059672
Pub Dt:
02/22/2024
Title:
METHOD OF PREPARING PRALSETINIB
Assignor
1
BLUEPRINT MEDICINES CORPORATION
Exec Dt:
02/22/2024
Assignee
1
RIGEL PHARMACEUTICALS, INC.
611 GATEWAY BLVD.
SUITE 900
SOUTH SAN FRANCISCO, CALIFORNIA 94080
Correspondence name and address
LISA SOLIS
GOODWIN PROCTER LLP
100 NORTHERN AVENUE
BOSTON, MA 02210

Search Results as of: 05/21/2024 11:40 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT